我們已在上線! 進一步了解
CEMI

Chembio diagnostics, Inc.

已下市

CEMI已於2023年4月27日下市。

 

關於: Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.

員工: 188

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於CEMI的最新新聞文章。

價格圖表採用Lightweight Charts™實作